Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Buy dildos and vibrators.
Popular Articles

Oxoid Makes Screening For Antibiotic-Resistant Organisms Faster, Allowing For Swifter Infection Control And Patient Treatment
Oxoid, a world leading microbiology brand, has today announced the availability of two new chromogenic media in the Brilliance™ Resistant Screening Agar range. Brilliance ESBL Agar and Brilliance VRE Agar can be used as screening tests to rapidly identify patients colonised with problematic Extended Spectrum Beta-Lactamase (ESBL) producing organisms and vancomycin resistant enterococci (VRE), allowing appropriate infection control and treatment to commence sooner for the best possible patient outcome.
buy viagra
Diabetes Wounds Healed With Oxygen Under Pressure
Every 30 seconds a person somewhere in the world loses a lower limb to amputation due to diabetic foot disease.
News of the day
Another Mystery In B Lymphocyte Development Solved By NYU School Of Medicine Pathology Researchers
A new study published online in Nature Immunology ahead of the June 2009 print issue has found that homologous immunoglobulin (lg) alleles pair up in the nucleus at stages that coincide with V(D)J recombination of the heavy and light chain (Igh and Igk) loci. Researchers led by Jane A. Skok Ph.D., assistant professor in the Department of Pathology at NYU School of Medicine and a member of the NYU Cancer Institute, showed that the V(D)J recombinase, which consists of the RAG1 and RAG2 proteins, mediates this pairing and helps ensure that only one allele undergoes recombination at a time (a process known as allelic exclusion).
Health Insurance

Editorial, Opinion Piece Discuss Issues Related To Routine HIV Testing

A recent directive to streamline the HIV testing consent process in Massachusetts as well as consent forms "no longer hav[ing] to accompany test specimens to the lab," are bringing "the state closer to a CDC recommendation that clinicians provide HIV screening on an opt-out basis," according to a Boston Globe editorial. "The opt-out provision is at the heart" of legislation sponsored by state Sen. Patricia Jehlen (D) that would end the state"s requirement of written consent for HIV testing "and instead have healthcare providers inform patients verbally that the test is planned but that they can decline it," the editorial states, adding, "The Jehlen bill would help destigmatize HIV testing itself" (7/6). Separately, an opinion piece in the Detroit Free Press - by David Share, medical director of the Corner Health Center and senior associate medical director of health care quality at Blue Cross Blue Shield of Michigan and Sandro Cinti, a clinical assistant professor in the Department of Internal Medicine at the University of Michigan-Ann Arbor - supports a Michigan bill (HB 4583) that would eliminate the written informed consent requirement in that state and replace it with a pamphlet and an informational opt-out form. Share and Cinti write of the current requirements, "These extraordinary precautions provide no protection, are not needed, and distract patients and health care professionals from other services and treatments that have the potential to improve patients" well-being," adding,"Routine HIV testing should be encouraged for early diagnosis and treatment of HIV infection" (Share/Cinti, 7/2). This information was reprinted from dailyreports.kff.org with kind permission from the Henry J. Kaiser Family Foundation. You can view the entire Kaiser Daily U.S. HIV/AIDS Report, search the archives and sign up for email delivery at dailyreports.kff.org. © Henry J. Kaiser Family Foundation. All rights reserved.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009